Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Caplin Point Laboratories Ltd Financial Statements & Historical Data

Updated NSE: CAPLIPOINTBSE: 524742
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 8 October 2026, 8:08 am +05:30. Financial reporting periods are shown in the tables below.

Stored share price2,649₹ per share
Reported P/E30.3Times
Book value per share443₹ per share
Reported ROCE24.2 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 8 October 2026, 8:08 am +05:30. Not a live quote.

MeasureStored figure
Market Cap20,136 Cr.
Current Price2,649
High / Low2,991/1,500
Stock P/E30.3
Book Value443
Dividend Yield0.30 %
ROCE24.2 %
ROE20.9 %
Face Value2.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Caplin Point Laboratories Ltd 20,136 Cr. 2,649 2,991/1,50030.3 4430.30 %24.2 %20.9 % 2.00
Shilpa Medicare Ltd 20,145 Cr. 1,030 1,096/26070.9 1320.06 %10.9 %8.99 % 1.00
Granules India Ltd 23,058 Cr. 845 924/52035.5 2050.21 %15.5 %13.8 % 1.00
Pfizer Ltd 17,073 Cr. 3,732 5,578/3,73222.2 9191.96 %24.1 %18.0 % 10.0
Cohance Lifesciences Ltd 16,932 Cr. 443 918/267157 1020.00 %5.81 %4.89 % 1.00
Industry Average17,219.37 Cr1,223.5053.77211.240.39%26.16%16.59%6.06

All Competitor Stocks of Caplin Point Laboratories Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 395410436453459483493502510534543600610
Expenses 269273293308307318331334332345353396397
Operating Profit 127137142145152165162168178189190204213
OPM % 32%34%33%32%33%34%33%33%35%35%35%34%35%
Other Income 12211717192131262330342834
Interest 0000000000000
Depreciation 11121416161716171618191922
Profit before tax 127146145146154168177177184201204213225
Tax % 18%20%18%17%19%22%21%18%18%20%19%19%20%
Net Profit 104116120121125131140145151160166173179
EPS in Rs 13.6215.1315.4316.0116.3117.2118.2818.7620.1020.3221.5622.3823.27

Last Updated: September 30, 2026, 12:01 am

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Mar 2016 covers 9 months. Values for periods of different lengths are not directly comparable.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Mar 2016 covers 9 months. Values for periods of different lengths are not directly comparable.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 27, 2026, 12:22 am

MetricJun 2014Jun 2015Mar 2016 (9 months)Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 1732522394025406498631,0611,2691,4671,6941,9372,1872,287
Expenses 1371921752763454176037328741,0251,1421,2871,4221,491
Operating Profit 366064125195232260329395442552651765797
OPM % 21%24%27%31%36%36%30%31%31%30%33%34%35%35%
Other Income 434101319412338556692111126
Interest 11011102111111
Depreciation 4871319233237474553667378
Profit before tax 365360121188227269314386451564677803844
Tax % 27%23%24%21%23%22%20%20%20%16%18%20%19%
Net Profit 26414696145177215251308377461541650678
EPS in Rs 3.425.436.0512.6519.1523.3528.4232.0339.5649.5760.1970.5684.3687.53
Dividend Payout % 23%18%20%12%10%9%9%9%10%9%8%8%9%

YoY Net Profit Growth

Year2017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)51.04%22.07%21.47%16.74%22.71%22.40%22.28%17.35%20.15%
Change in YoY Net Profit Growth (%)0.00%-28.97%-0.60%-4.72%5.96%-0.31%-0.12%-4.93%2.79%

Caplin Point Laboratories Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2017-2018 to 2025-2026.

Growth

Compounded Sales Growth
10 Years:27%
5 Years:18%
3 Years:15%
TTM:13%
Compounded Profit Growth
10 Years:35%
5 Years:20%
3 Years:21%
TTM:18%
Stock Price CAGR
10 Years:22%
5 Years:32%
3 Years:40%
1 Year:8%
Return on Equity
10 Years:27%
5 Years:24%
3 Years:23%
Last Year:22%

Last Updated: September 5, 2025, 1:35 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 27, 2026, 12:22 am

MonthJun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 151515151515151515151515
Reserves 781132103495828589541,2521,6492,0842,6193,355
Borrowings 221136113235219222219222221
Other Liabilities 134137133136109139159250305380352446
Total Liabilities 2292673585007431,1261,3641,7362,1912,6983,2084,038
Fixed Assets 113144152169227272305287280453546580
CWIP 31031510201418221117144234
Investments 00174770611189281376590859
Other Assets 851221862694367721,0331,3431,4101,7531,9282,365
Total Assets 2292673585007431,1261,3641,7362,1912,6983,2084,038
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthJun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 504268668345269337271318432523
Cash from Investing Activity + -23-6-36-69-100-54-30-377-216-319-333-582
Cash from Financing Activity + -9-14-7-129080-24-41-28-38-38-46
Net Cash Flow 192325-147370215-8127-3961-105
Free Cash Flow 2434431818-3219524678173241275
CFO/OP 103%92%73%53%54%38%102%106%81%77%86%87%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodJun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow24.0034.0043.0018.0018.00-32.00195.00246.0078.00173.00241.00275.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthJun 2014Jun 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 081230859097969198117119
Inventory Days 353757444447210139149159183159
Days Payable 11211216815514476576810284106103
Cash Conversion Cycle -77-67-99-81-1661251166138173194175
Working Capital Days -181-128-114-2947104167145165144166233
ROCE %64%68%62%68%63%45%33%28%28%26%26%26%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 70.62%70.62%70.62%70.56%70.56%70.56%70.56%70.56%70.57%70.57%70.57%70.57%
FIIs 3.09%2.84%3.33%3.38%3.71%4.86%5.73%6.16%6.51%6.58%6.15%5.76%
DIIs 0.21%0.43%1.08%1.49%1.83%2.11%2.00%2.22%2.10%2.05%2.14%2.49%
Public 26.08%26.11%24.95%24.59%23.93%22.48%21.72%21.06%20.82%20.81%21.14%21.19%
No. of Shareholders 78,06879,43881,40980,41196,12392,70296,38794,16993,75393,70593,89694,385
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
UTI Small Cap Fund 376,835 1.47 66.85363,1492026-01-25 05:11:423.77%
UTI Large & Mid Cap Fund 301,541 0.95 53.49300,7012026-02-22 05:22:410.28%
UTI Aggressive Hybrid Fund 278,474 0.74 49.4277,3532026-02-22 05:22:410.4%
UTI Healthcare Fund 145,000 2.44 25.72130,8372026-01-25 05:11:4210.82%
UTI Retirement Fund 108,425 0.41 19.23107,5852026-02-22 05:22:410.78%
ITI Pharma and Healthcare Fund 10,449 0.88 1.859,8672025-12-15 04:31:045.9%

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 70.5760.1949.6239.6132.03
Diluted EPS (Rs.) 70.2559.9049.1839.2631.71
Cash EPS (Rs.) 79.8867.7955.6046.8838.13
Book Value[Excl.RevalReserv]/Share (Rs.) 365.25299.18241.46189.35159.08
Book Value[Incl.RevalReserv]/Share (Rs.) 365.25299.18241.46189.35159.08
Revenue From Operations / Share (Rs.) 254.93223.05193.25167.47140.30
PBDIT / Share (Rs.) 97.8181.4265.4957.1846.56
PBIT / Share (Rs.) 89.1374.3859.5650.9941.67
PBT / Share (Rs.) 89.0574.3259.4750.9041.46
Net Profit / Share (Rs.) 71.2060.7549.6740.6933.24
NP After MI And SOA / Share (Rs.) 70.5760.1849.5739.5632.03
PBDIT Margin (%) 38.3636.5033.8834.1433.18
PBIT Margin (%) 34.9633.3430.8230.4429.70
PBT Margin (%) 34.9333.3130.7730.3929.55
Net Profit Margin (%) 27.9227.2325.7024.2923.69
NP After MI And SOA Margin (%) 27.6826.9825.6523.6222.82
Return on Networth / Equity (%) 19.3220.3920.8321.2720.43
Return on Capital Employeed (%) 23.3423.8623.5025.2825.82
Return On Assets (%) 16.7116.9417.1617.2617.76
Total Debt / Equity (X) 0.000.000.000.000.01
Asset Turnover Ratio (%) 0.650.690.740.430.48
Current Ratio (X) 6.975.715.806.257.25
Quick Ratio (X) 5.884.624.725.156.00
Inventory Turnover Ratio (X) 5.540.730.801.410.85
Dividend Payout Ratio (NP) (%) 0.007.478.050.001.24
Dividend Payout Ratio (CP) (%) 0.006.697.190.001.08
Earning Retention Ratio (%) 0.0092.5391.950.0098.76
Cash Earning Retention Ratio (%) 0.0093.3192.810.0098.92
Interest Coverage Ratio (X) 1218.62792.79637.23619.17221.55
Interest Coverage Ratio (Post Tax) (X) 888.05592.22484.22441.64159.17
Enterprise Value (Cr.) 14664.809483.554065.674717.102632.14
EV / Net Operating Revenue (X) 7.575.602.773.722.48
EV / EBITDA (X) 19.7315.348.1810.887.47
MarketCap / Net Operating Revenue (X) 7.865.913.094.062.88
Retention Ratios (%) 0.0092.5291.940.0098.75
Price / BV (X) 5.484.462.513.662.58
Price / Net Operating Revenue (X) 7.865.913.094.062.88
EarningsYield 0.030.040.080.050.07
Advertisements
Explore Industry-wise Company financial data